Lv4
448 积分 2024-06-03 加入
Can non-canonical amino acids open up non-canonical drug discovery opportunities?
17天前
已完结
Covalent drug discovery using sulfur(VI) fluoride exchange warheads
24天前
已完结
Chemically Engineered Affinity Protein Drugs for Covalent Targeted Cancer Therapy
24天前
已完结
AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl
1个月前
已完结
Molecular Design of Unimolecular Tetra-Receptor Agonists
2个月前
已完结
De Novo Synthesis of Lacto-N-Neotetraose in Escherichia coli through Metabolic Engineering with Glucose as the Sole Carbon Source
2个月前
已完结
Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants
3个月前
已完结
Novel strategies exploiting interleukin-12 in cancer immunotherapy
6个月前
已完结
Development of a novel Fc fusion protein dual glucagon-like peptide-1 and gastric inhibitory polypeptide receptor agonists
8个月前
已完结
After GLP-1, what’s next for weight loss?
9个月前
已完结
皖公网安备34019202002308
